Tag: Cancer
-
Clinical Trials Show Promise in Leukemia
Two drugs that target mutations in leukemia showed encouraging results, according to recent clinical trials.
-
Men With Aggressive Prostate Cancer May Get New Powerful Drug Option
An existing drug significantly lowered the risk of metastasis or death when used in men with non-metastatic castrate-resistant prostate cancer and a rising PSA level, according to a study published in the New England Journal of Medicine.
-
Common Antimicrobial May Raise Risk of Colon Disease
Triclosan, a common antimicrobial used in toothpastes and other products, may raise the risk of gut inflammation and colorectal cancer, according to a preliminary animal study.
-
Rare Bacteria Boosts Immunotherapy in Prostate Cancer
A unique bacterial strain isolated from a patient with pelvic pain could be the key to treating prostate cancer with immunotherapy, according to a study published in Nature Communications.
-
Resident Investigates Radiation Therapy Benefit in Breast Cancer
The presence of cancer cells in the bloodstream of patients with early-stage breast cancer may be predictive of benefit from radiotherapy after surgery, according to a new Northwestern Medicine study.
-
Resetting the Epigenetic Balance for Cancer Therapy
Northwestern Medicine scientists have discovered an epigenetic imbalance that can lead to cancer, and used these findings to inhibit tumors in models.
-
A New Weapon Against Cancer Metastasis
Northwestern Medicine scientists have discovered a new compound that halts the spread of multiple types of cancer cells.
-
Enzyme Blocker Stops Growth of Deadly Brain Tumor
Scientists discovered the regulatory role of the enzyme CDK5 in an aggressive form of brain cancer and successfully halted tumor growth by inhibiting it.
-
Evaluating Drug Regimens for High-Risk Prostate Cancer
The addition of a chemotherapy drug to adjuvant hormone therapy did not improve survival for patients with high-risk prostate cancer, according to a new study.
-
Precision Pathologist
New chair Daniel Brat, MD, PhD, is spearheading transformations in pathology, a field that’s rapidly evolving in parallel with advances in precision medicine and a trend toward sub-specialization.
